FGFR2 GENE FUSION/REARRANGEMENT

Clinical trials for FGFR2 GENE FUSION/REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new FGFR2 GENE FUSION/REARRANGEMENT trials appear

Sign up with your email to follow new studies for FGFR2 GENE FUSION/REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New drug targets genetic driver in advanced cancers

Disease control Not yet recruiting

This study is testing whether an experimental drug called lirafugratinib can help control advanced solid tumors that have a specific genetic change called FGFR2 fusion or rearrangement. The trial is for adults whose cancer has spread or cannot be surgically removed and who have a…

Matched conditions: FGFR2 GENE FUSION/REARRANGEMENT

Phase: PHASE2 • Sponsor: Elevar Therapeutics • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

FGFR2 GENE FUSION/REARRANGEMENT

Get alerted when new FGFR2 GENE FUSION/REARRANGEMENT trials appear

New drug targets genetic driver in advanced cancers